Furthermore, several powerful tautomerase inhibitors, highly selective for human MIF, have recently been identified and Adamali et al. showed promising ex-vivo results regarding their use to tame MIF-sustained immune reaction in CF patients [20], [37], [38]. This evidence concerns the gene MIF and cystic fibrosis.